Addressing the relationship between cardiac hypertrophy and ischaemic stroke: An observational study

International Archives of Medicine

Volumn 5, Issue 1, 2012, Pages

  Rodrigo, Chaturaka ^a   Weerasinghe, Sajitha ^b   Jeevagan, Vijayabala ^b   Rajapakse, Senaka ^a   Constantine, Godwin ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b NATIONAL HOSPITAL OF SRI LANKA   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; COHORT ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SRI LANKA;

EID: 84870952681     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-5-32     Document Type: Article

References (31)

1. Left ventricular hypertrophy: an overlooked cardiovascular risk factor. Bauml MA, Underwood DA, Cleve Clin J Med 2010 77 381 387 10.3949/ccjm.77a.09158 20516249
2. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Pede S, Reboldi GP, Am J Hypertens 2006 19 493 499 10.1016/j.amjhyper.2005.10.018 16647622
3. Population-attributable risks for ischemic stroke in a community in South Brazil: a case-control study. Mallmann AB, Fuchs SC, Gus M, Fuchs FD, Moreira LB, PLoS One 2012 7 35680 10.1371/journal.pone.0035680 22530066
4. A study of risk factors of stroke in patients admitted in Manipal Teaching Hospital. Maskey A, Parajuli M, Kohli SC, Pokhara. Kathmandu Univ Med J (KUMJ) 2011 9 244 247
5. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C, Lancet 1991 337 1521 1526 10.1016/0140-6736(91)93206-O 1675378
6. Cornell voltage criteria. Carey MG, Pelter MM, Am J Crit Care 2008 17 273 274 18450685
7. Recommendations for chamber quantification. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, et al. Eur J Echocardiogr 2006 7 79 108 10.1016/j.euje.2005.12.014 16458610 (Pubitemid 43257193)
8. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N, Am J Cardiol 1986 57 450 458 10.1016/0002-9149(86)90771-X 2936235 (Pubitemid 16119719)
9. Echocardiographic assessment of hypertensive left ventricular hypertrophy in patients with acute ischemic stroke or transient ischemic attack. Castilla-Guerra L, Fernandez-Moreno MD, Alvarez-Suero J, Gonzalez A, J Stroke Cerebrovasc Dis 2011
10. Prevalence of transthoracic echocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Amin H, Aronow WS, Lleva P, McClung JA, Desai H, Gandhi K, Marks S, Singh B, Arch Med Sci 2010 6 40 42 22371718
11. Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study. Fox ER, Alnabhan N, Penman AD, Butler KR, Taylor HA Jr, Skelton TN, Mosley TH Jr, Stroke 2007 38 2686 2691 10.1161/STROKEAHA.107.485425 17761924 (Pubitemid 47500093)
12. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Tanne D, Yaari S, Goldbourt U, Circulation 1998 98 1365 1371 10.1161/01.CIR.98.14.1365 9760289 (Pubitemid 28462795)
13. Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up. Wiberg B, Sundstrom J, Arnlov J, Terent A, Vessby B, Zethelius B, Lind L, Stroke 2006 37 2898 2903 10.1161/01.STR.0000249056.24657.8b 17053177 (Pubitemid 44900808)
14. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. The Dutch TIA Trial Study Group. Stroke 1993 24 527 531 http://www.ncbi.nlm.nih.gov/pubmed/8465356 8465356
15. Left ventricular mass and geometry and the risk of ischemic stroke. Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S, Stroke 2003 34 2380 2384 10.1161/01.STR.0000089680.77236.60 12958319 (Pubitemid 37221946)
16. Physical activity attenuates the effect of increased left ventricular mass on the risk of ischemic stroke: The Northern Manhattan Stroke Study. Rodriguez CJ, Sacco RL, Sciacca RR, Boden-Albala B, Homma S, Di Tullio MR, J Am Coll Cardiol 2002 39 1482 1488 10.1016/S0735-1097(02)01799-0 11985911 (Pubitemid 34439064)
17. Ischemic stroke: prevalence of modifiable risk factors in male and female patients in Pakistan. Khan NI, Naz L, Mushtaq S, Rukh L, Ali S, Hussain Z, Pak J Pharm Sci 2009 22 62 67 19168423
18. Risk factors for ischemic stroke: electrocardiographic findings. Chiu EH, Tan TY, Chang KC, Liou CW, Acta Neurol Taiwan 2006 15 232 236 17214085 (Pubitemid 46033245)
19. Risk factors for first-ever ischemic stroke: a hospital-based case-control study in Kaohsiung, Taiwan. Tan TY, Tseng MC, Chang KC, Chang Gung Med J 2004 27 801 807 15796255
20. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke. Kohsaka S, Sciacca RR, Sugioka K, Sacco RL, Homma S, Di Tullio MR, Am Heart J 2005 149 181 186 10.1016/j.ahj.2004.06.006 15660051 (Pubitemid 40126507)
21. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. Lanni F, Santulli G, Izzo R, Rubattu S, Zanda B, Volpe M, Iaccarino G, Trimarco B, J Hypertens 2007 25 551 556 10.1097/HJH.0b013e328013cd67 17278970 (Pubitemid 46213792)
22. Framingham Heart Study 100 K Project: genome-wide associations for blood pressure and arterial stiffness. Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, Hwang SJ, Vasan RS, Mitchell GF, BMC Med Genet 2007 8 3 10.1186/1471-2350-8-S1-S3 17903302 (Pubitemid 351958756)
23. CaMK4 Gene deletion induces hypertension. Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, et al. J Am Heart Assoc 2012 1 001081 10.1161/JAHA.112.001081 23130158
24. Involvement of nuclear factor-B and apoptosis signal-regulating kinase 1 in g-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, et al. Circulation 2002 105 509 515 10.1161/hc0402.102863 11815436 (Pubitemid 34141710)
25. Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Sorriento D, Santulli G, Fusco A, Anastasio A, Trimarco B, Iaccarino G, Hypertension 2010 56 696 704 10.1161/HYPERTENSIONAHA.110.155960 20660817
26. Vascular risk factors and cognitive impairment in a stroke-free cohort. Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela BM, Kelley BJ, Kennedy R, Moy CS, et al. Neurology 2011 77 1729 1736 10.1212/WNL.0b013e318236ef23 22067959
27. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, et al. JAMA 2004 292 2343 2349 10.1001/jama.292.19.2343 15547161 (Pubitemid 39491918)
28. Coronary heart disease risk factors and mortality. Santulli G, JAMA 2012 307 1137 22436948
29. Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. Knöll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D, Bauersachs J, Leite-Moreira AF, Sugden PH, Balligand J-L, Eur J Hear Fail 2011 13 811 819 10.1093/eurjhf/hfr071
30. Reduction in estimated stroke risk associated with practice-based stroke-risk assessment and awareness in a large, representative population of hypertensive patients: results from the ForLife study in Italy. Volpe M, Rosei EA, Ambrosioni E, Leonetti G, Trimarco B, Mancia G, J Hypertens 2007 25 2390 2397 10.1097/HJH.0b013e3282efc5a2 17984659 (Pubitemid 350060378)
31. The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade. Chrysant SG, Chrysant GS, Chrysant C, Shiraz M, Curr Clin Pharmacol 2010 5 89 95 10.2174/157488410791110742 20156154